International
The Morning Science

What science found today

‹
 

Launch

FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

MedPage Today ·

FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

The Brief

  • The FDA approved venglustat (brand name Infilbray) tablets.
  • It is the first treatment for neurologic symptoms of type 3 Gaucher disease.
  • It is approved for adults and children weighing at least 15 kg.

Why it matters

It gives clinicians the first approved option for the neurologic symptoms of type 3 Gaucher disease, a rare inherited condition that previously lacked a treatment targeting those symptoms.

Who’s affected

  • clinicians treating patients with type 3 Gaucher disease
  • patients and families affected by Gaucher disease
  • neurologists

(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...

Timeline

  1. FDA approval of venglustat for neurologic symptoms of type 3 Gaucher disease, as reported by MedPage Today

  2. MedPageToday.com - medical news for physicians

    FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

How do you feel about this?

0 Comments